The novel oncolytic adenoviral mutant Ad5-3 Delta-A20T retargeted to alpha v beta 6-integrins efficiently eliminates pancreatic cancer cells
dc.contributor.author | Man, YKS | en_US |
dc.contributor.author | Davies, JA | en_US |
dc.contributor.author | Coughlan, L | en_US |
dc.contributor.author | Pantelidou, C | en_US |
dc.contributor.author | Marshall, JF | en_US |
dc.contributor.author | Parker, AL | en_US |
dc.contributor.author | Hallden, G | en_US |
dc.date.accessioned | 2020-08-13T09:47:00Z | |
dc.date.issued | 2017-12 | en_US |
dc.identifier.issn | 1043-0342 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/66249 | |
dc.format.extent | A27 - A27 | en_US |
dc.title | The novel oncolytic adenoviral mutant Ad5-3 Delta-A20T retargeted to alpha v beta 6-integrins efficiently eliminates pancreatic cancer cells | en_US |
dc.type | Conference Proceeding | |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000418410700077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 12 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 28 | en_US |